Skip to main content

ROYAL BANK OF CANADA

Bank

Position in DNLI — Denali Therapeutics Inc.

CIK 1000275 TORONTO, A6

Position in DNLI

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$359,409
+$214,739 QoQ
Shares Held
13,974
+85.5% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#168
of 290 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in DNLI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ROYAL BANK OF CANADA holds $2,116,200,724 across 427 Biotechnology names. DNLI ranks #91 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in DNLI

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $359,409 13,974
2026-03-31 $144,670 7,535
2025-12-31 $187,139 11,335
2025-09-30 $5,403,993 372,176
2025-06-30 $5,458,266 390,155
2025-03-31 $196,256 14,436
2024-12-31 $356,873 17,511
2024-09-30 $638,847 21,931
2024-06-30 $354,776 15,279
2024-03-31 $144,849 7,059
2023-12-31 $833,525 38,841
2023-09-30 $370,802 17,974
2023-06-30 $310,325 10,516
2023-03-31 $209,363 9,087
2022-12-31 $534,533 19,221
2022-09-30 $123,219 4,015
2022-06-30 $394,567 13,407
2022-03-31 $269,616 8,381
2021-12-31 $412,237 9,243
2021-09-30 $205,230 4,068
2021-06-30 $891,391 11,364
2021-03-31 $2,054,514 35,981
2020-12-31 $2,005,296 23,941
2020-09-30 $57,328 1,600
2020-06-30 $31,192 1,290
2020-03-31 $25,266 1,443